The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...
Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...